SiSU Health Expands with £1.25 Million Investment from NPIF II and GMC Life Sciences
Deal News | Apr 09, 2025 | praetura ventures
SiSU Health, a health platform focused on prevention and addressing health inequalities, has secured £1.25 million in funding from Praetura Ventures to expand its team and accelerate its digital health solutions across the UK and Europe. The investment comes from the GMC Life Sciences Fund by Praetura, including partners like Bruntwood SciTech and the Greater Manchester Combined Authority. Additionally, NPIF II Praetura Equity Finance has participated, managed under the Northern Powerhouse Investment Fund II. This funding will help SiSU Health extend its reach, expand its network of health stations, and drive operations in Manchester. SiSU Health's comprehensive solution combines technology, data analytics, and behavioral science, aiming to reduce the strain on NHS services and encourage healthier lifestyles. With over one million health checks delivered, the platform highlights the need for proactive health interventions. CEO Samantha Fay emphasizes the importance of accessible and data-informed health tools. This marks the fifth co-investment by the two funds in the past year.
Sectors
- Health Technology
- Venture Capital
Geography
- United Kingdom – The investment is aimed at expanding SiSU Health's reach across the UK, and operations are focused in Manchester.
- Europe – SiSU Health plans to extend its digital health solutions beyond the UK into Europe.
Industry
- Health Technology – SiSU Health is a tech company providing digital health solutions aimed at prevention and early intervention.
- Venture Capital – The investment from Praetura Ventures, a VC firm, indicates venture capital involvement in the funding of SiSU Health.
Financials
- £1.25 million – Total investment secured from Praetura Ventures and partners to expand SiSU Health's operations.
- £103 billion – Estimated cost of employee sickness to UK GDP, according to the Institute for Public Policy Research.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| SiSU Health | Target | Company | Digital health platform focused on prevention and early intervention, expanding operations in the UK and Europe. |
| Praetura Ventures | Investor | Company | VC firm providing £1.25 million funding to SiSU Health for expansion. |
| GMC Life Sciences Fund by Praetura | Investor | Company | Fund contributing to the £1.25 million investment, aiming to boost the life sciences industry in the North West. |
| NPIF II Praetura Equity Finance | Investor | Company | Part of the Northern Powerhouse Investment Fund II, co-investing in SiSU Health's expansion. |
| Bruntwood SciTech | Partner | Company | Part of the GMC Life Sciences Fund by Praetura, supporting the investment in SiSU Health. |
| Greater Manchester Combined Authority | Partner | Government | Partner in the GMC Life Sciences Fund by Praetura, supporting regional life sciences growth. |
| Enterprise Cheshire and Warrington | Partner | Government | Involved in the GMC Life Sciences Fund by Praetura as a supporting partner. |
| British Business Bank | Partner | Company | Providing support to Northern Powerhouse Investment Fund II, promoting innovation in the UK. |
| Samantha Fay | CEO | Person | CEO of SiSU Health, leading the expansion and strategic direction of the company. |